SEALSQ (LAES) VP Enguent Jean‑Pierre Sells 15,000 Shares

What Happened

• Enguent Jean‑Pierre, Vice President, R&DSS at SEALSQ Corp (ticker: LAES), exercised stock options and sold shares. On 2026-08-03 he exercised or converted 15,000 shares at $0.01 (cost $150) and reported a related derivative disposition of 15,000 shares at $0.00. On 2026-08-05 he sold 15,000 shares in the open market at a weighted average price of $2.46, resulting in proceeds of about $36,857.
• The activity included option exercise followed by a sale of shares (net effect: converted options into stock and sold those shares). Sales are typically routine insider liquidity but do not by themselves indicate company outlook.

Key Details

• Transaction dates and prices:
  • 2026-08-03: Option exercise/conversion — 15,000 shares acquired at $0.01 (total $150).
  • 2026-08-03: Derivative disposition — 15,000 shares reported disposed at $0.00 (reported as derivative).
  • 2026-08-05: Open‑market sale — 15,000 shares sold at weighted avg $2.46 (range $2.4313–$2.51) for ~$36,857.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnotes: Both the option exercise and the sale were effected pursuant to a Rule 10b5‑1 trading plan adopted by Jean‑Pierre on October 13, 2025 (Footnotes F1, F3). The sale price is a weighted average; the filer will provide per‑trade prices on request (Footnote F2).
• Filing timeliness: Form filed on 2026-08-05 for transactions reported as of 2026-08-03 (appears timely under Form 4 rules).

Context

• For retail investors: this was an exercise of derivative rights (options) followed by a sale — effectively a cash‑out of option gains. That pattern is common when insiders use 10b5‑1 plans to systematically sell acquired shares.
• The presence of a 10b5‑1 plan means sales were pre‑scheduled; this reduces the implication that the sale reflects a new, private view about the company.